Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
about
In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.The pattern recognition reagents RAGE VC1 and peptide p5 share common binding sites and exhibit specific reactivity with AA amyloid in miceReview of eprodisate for the treatment of renal disease in AA amyloidosis.Development and evaluation of agents for targeting visceral amyloid.Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence.Kinetics of glycosaminoglycan deposition in splenic AA amyloidosis induced in mink.Glycosaminoglycans are part of amyloid fibrils: ultrastructural evidence in avian AA amyloid stained with cuprolinic blue and labeled with immunogold.Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells.Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.Proteoglycans and the extracellular matrix in amyloidosisDiet, amyloid enhancing factor (AEF) and amyloidogenesis: An hypothesis
P2860
Q35180876-A249FCA4-D63F-45B0-8CF6-6BAD58A8A843Q35656129-44EA5CA9-8D84-451C-B7AA-9198BEE03D47Q36800611-F55BB826-BB11-4BB5-B530-74A3BA2FDEFBQ37994670-50CB4F58-1C8E-40D1-8F03-7C554D919F8BQ41814084-0F8D5C5E-69CA-4DF2-9AE6-F3ADAE42BE72Q43248445-6C10BEA4-E9BF-4CFF-AFAC-4AA998E760BBQ46766505-67C80894-0CF4-438C-BA4B-0495B266BC97Q50479496-C0B612F2-0010-40AF-9059-C085C76656ECQ52993068-6392C327-423B-4E13-AFEA-F8BC8757C313Q53201071-6DDF49E7-D3EC-4507-BE73-06A367F9F901Q53877605-E8A6FAC3-AC84-4024-BE2B-53E572073D72Q58283024-17CC3C28-611B-455F-8E9B-EC42684B1A7CQ58285765-F7016020-2EE1-4357-BF1C-3F53F20B9F37
P2860
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@en
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@nl
type
label
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@en
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@nl
prefLabel
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@en
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
@en
P2093
P2860
P304
P356
10.1042/BJ3030663
P407
P478
303 ( Pt 2)
P577
1994-10-01T00:00:00Z